Inactive on SAM.gov — responses were due 28 Aug 2026 · Unrestricted (full and open) · Department of Veterans Affairs (VA) · NAICS 334516 · Solicitation 36C24826Q1168
Following NAICS 334516? Get new solicitations in it by email as they post — no account needed.
SAM.gov marked this notice inactive — responses were due 28 August 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
This one has closed. We'll email you when new NAICS 334516 (Analytical Laboratory Instrument Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
The Department of Veterans Affairs, NCO 8, intends to award a sole source, firm fixed price contract under FAR 6.302 1, Only One Responsible Source, to QIAGEN LLC, Germantown, MD, for QuantiFERON (QFT) TB Gold Plus II reagents and controls used for Interferon Gamma Release Assay (IGRA) testing at the James A. Haley Veterans Hospital (JAHVH). The contract will be established as a five year BPA (Base Year + 4 Option Years). The applicable NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), PSC 6640. This notice is not a solicitation. No solicitation will be issued. The Government intends to solicit and negotiate with only one source, as the required QuantiFERON TB Gold Plus II reagents are exclusively manufactured by QIAGEN and are uniquely compatible with the DiaSorin LIAISON XL analyzer currently in use at JAHVH. Interested parties may submit capability statements demonstrating the ability to provide fully compatible supplies no later than 10:00 AM ET, August 28, 2026, to Quentin.Ford@va.gov. Proprietary information must be clearly marked. The Government will evaluate responses solely to determine whether competition is viable; however, a decision not to compete remains at the Government s discretion. Point of Contact: Quentin Ford, Contracting Officer, NCO 8 Statement of Need QIAGEN QuantiFERON TB Gold Plus II Reagents and Controls Overview: The Pathology and Laboratory Medicine Service at JAHVH requires FDA approved, DiaSorin compatible reagents and controls for QuantiFERON TB Gold Plus II testing to support in house IGRA testing for Veterans and employee TB screening. Requirement Summary: Provide QIAGEN QuantiFERON TB Gold Plus II reagents and controls fully compatible with the DiaSorin LIAISON XL analyzer. Support continuous IGRA testing for clinical and occupational health needs. Furnish monthly deliveries of required reagents; shipping included. Supply products meeting CAP, JCAHO, and VA laboratory standards. No site preparation required equipment already installed. Routine daily maintenance and QC performed by VA staff. Equipment maintenance is covered under a separate DiaSorin service contract.
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
